| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 13,904 | 20,352 | 21,777 | | Cost of Revenue | 902 | 1,347 | 1,231 | | | Gross Profit | 13,002 | 19,006 | 20,545 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 343 | 413 | 319 | | Non Recurring |
-
|
-
|
-
| | Others | 18 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 12,641 | 18,592 | 20,227 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (64,147) | (32,148) | (2,261) | | Earnings Before Interest And Taxes | 12,641 | 18,592 | 17,966 | | Interest Expense | 1,529 | 191 | 192 | | Income Before Tax | 11,111 | 18,402 | 17,774 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (53,036) | (13,746) | 17,774 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (53,036) | (13,746) | 17,774 | | Preferred Stock And Other Adjustments | (874) | (4,289) | (3,077) | | | Net Income Applicable To Common Shares | ($53,909) | ($18,035) | $14,697 |
|
0.31% Nasdaq 
0.05%
Income Statement
